(Q35939972)

11 August 2017

Association of dopamine receptor polymorphisms with schizophrenia and antipsychotic response in a South Indian population (English)

1 reference

11 August 2017

0 references

0 references

Chandrasekharan M Nair

6

0 references

Chandrasekhar Natarajan

object named as

Chandrasekhar Natarajan

4

0 references

author name string

Neetha N Vijayan

1

1 reference

11 August 2017

Sujatha Bhaskaran

2

1 reference

11 August 2017

Linda V Koshy

3

1 reference

11 August 2017

Lekshmy Srinivas

5

1 reference

11 August 2017

Priya M Allencherry

7

1 reference

11 August 2017

Moinak Banerjee

8

1 reference

11 August 2017

language of work or name

English

0 references

publication date

25 July 2007

1 reference

Behavioral and Brain Functions

11 August 2017

1 reference

11 August 2017

3

1 reference

11 August 2017

34

1 reference

https://scigraph.springernature.com/pub.10.1186/1744-9081-3-34

11 August 2017

0 references

cites work

Ethnic variation in symptoms and response to risperidone in youths with schizophrenia-spectrum disorders.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1947997

A systematic review of the prevalence of schizophrenia

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1947997

Pharmacogenetic studies of response to risperidone and other newer atypical antipsychotics

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1947997

Pharmacogenetics of dopamine receptors and response to antipsychotic drugs in schizophrenia--an update

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1947997

Haploview: analysis and visualization of LD and haplotype maps

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1947997

Focus on psychiatry in India

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1947997

Racial disparities in antipsychotic prescription patterns for patients with schizophrenia

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1947997

Atypical antipsychotics: mechanism of action.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1947997

The DRD2 gene in psychiatric and neurological disorders and its phenotypes

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1947997

Comorbid migraine with aura, anxiety, and depression is associated with dopamine D2 receptor (DRD2) NcoI alleles

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1947997

Race, quality of care, and antipsychotic prescribing practices in psychiatric emergency services

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1947997

The genetics of schizophrenia: a current, genetic-epidemiologic perspective

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1947997

Chemical brain anatomy in schizophrenia.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1947997

Dopamine receptors and the dopamine hypothesis of schizophrenia

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1947997

Dopamine in schizophrenia: a review and reconceptualization

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1947997

Antipsychotic drug doses and neuroleptic/dopamine receptors

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1947997

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1947997

Dopamine DRD2/Cys311 is not associated with chronic schizophrenia

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1947997

No structural mutation in the dopamine D2 receptor gene in alcoholism or schizophrenia. Analysis using denaturing gradient gel electrophoresis.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1947997

PCR detection of the TaqA RFLP at the DRD2 locus.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1947997

A structural polymorphism of human dopamine D2 receptor, D2(Ser311-->Cys).

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1947997

Receptor activity and turnover of dopamine and noradrenaline after neuroleptics

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1947997

DRD2 promoter region variation as a predictor of sustained response to antipsychotic medication in first-episode schizophrenia patients

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1947997

Association of DRD2 gene variant with schizophrenia

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1947997

Association study of 12 polymorphisms spanning the dopamine D(2) receptor gene and clozapine treatment response in two treatment refractory/intolerant populations

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1947997

Meta-analysis identifies an association between the dopamine D2 receptor gene and schizophrenia

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1947997

Pedigree disequilibrium tests for multilocus haplotypes.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1947997

L -dopa-induced adverse effects in PD and dopamine transporter gene polymorphism

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1947997

Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1947997

The influence on the schizophrenic symptoms by the DRD2Ser/Cys311 and -141C Ins/Del polymorphisms

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1947997

Association of short-term response to haloperidol treatment with a polymorphism in the dopamine D(2) receptor gene

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1947997

Association analysis between two functional dopamine D2 receptor gene polymorphisms and schizophrenia

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1947997

A Ser311Cys mutation in the human dopamine receptor D2 gene is associated with reduced energy expenditure

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1947997

Recent patterns and predictors of antipsychotic medication regimens used to treat schizophrenia and other psychotic disorders.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1947997

Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1947997

Ser-311-Cys polymorphism of the dopamine D2 receptor gene and schizophrenia--an analysis of schizophrenic patients in Fukuoka.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1947997

Ethnicity and treatment response in schizophrenia: a comparison of 3 ethnic groups

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1947997

No association of dopamine D2 receptor molecular variant Cys311 and schizophrenia in Chinese patients

24 September 2018

1 reference

12 December 2020

Dopamine receptor D2 Ser/Cys 311 variant is associated with delusion and disorganization symptomatology in major psychoses

1 reference

12 December 2020

Component structure of the expanded Brief Psychiatric Rating Scale (BPRS-E)

1 reference

12 December 2020

Further association study on dopamine D2 receptor variant S311C in schizophrenia and affective disorders

1 reference

12 December 2020

Association of structural polymorphism of the dopamine D2 receptor gene and alcoholism

1 reference

12 December 2020

Lack of association between dopamine D2 receptor gene Cys311 variant and schizophrenia

1 reference

12 December 2020

Use of BPRS-A percent change scores to identify significant clinical improvement: accuracy of treatment response classification in acute psychiatric inpatients

1 reference

12 December 2020

Mismatch PCR RFLP detection of DRD2 Ser311Cys polymorphism and schizophrenia

1 reference

12 December 2020

No evidence for association of dopamine D2 receptor variant (Ser311/Cys311) with major psychosis

1 reference

12 December 2020

Schizophrenia: WHO study shows that patients fare better in developing countries

1 reference

12 December 2020

No association of the Ser/Cys311 DRD2 molecular variant with schizophrenia using a classical case control study and the haplotype relative risk

1 reference

12 December 2020

DRD2 Ser311/Cys311 polymorphism in schizophrenia

1 reference

12 December 2020

The relationship between dopamine D2 receptor polymorphism at the Taq1 A locus and therapeutic response to nemonapride, a selective dopamine antagonist, in schizophrenic patients

1 reference

12 December 2020

Association of dopamine D2 receptor molecular variant with schizophrenia

1 reference

12 December 2020

No major role for the dopamine D2 receptor Ser-->Cys311 mutation in schizophrenia

1 reference

12 December 2020

[Association of allele polymorphism of dopamine d2 receptors with schizophrenic and affective disorders]

1 reference

12 December 2020

Identifiers

DOI

10.1186/1744-9081-3-34

1 reference

11 August 2017

1 reference

11 August 2017

1 reference